Clinical Trial

Cortisone Injection and Splinting for Trigger Finger

Study Description

Effectiveness of Cortisone Injection and Splinting for Trigger Finger

Trigger finger has a prevalence rate of up to 3%. There are many approaches available to manage this condition. While corticosteroid injection is widely accepted as the most common first-line treatment, its superiority over splint treatment has not been established. This study aims to test the effectiveness of cortisone injections, splint and cortisone+splint to resolve symptoms.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Splint

Custom made splint

Drug - Betamethasone

Corticosteroid Injection Brand name of the drug: Celestone Soluspan Dosage: 6 mg/ml

Combination Product - Splint + Cortico-steroid injection

Splint + Cortico-steroid injection given in combination

Additional Information

Official Study Title

Effectiveness of Cortisone Injection and Splinting for Trigger Finger: A Prospective Randomized Controlled Trial

Clinical Trial ID

NCT03156829

ParticipAid ID

xboBja